MANNITOL
GERD
Pichamol Jirapinyo, MD, MPHSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the GERD cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PANTOPRAZOLE Children's Mercy Hospital Kansas City | Phase 4 | BB |
Lansoprazole Children's Mercy Hospital Kansas City | Phase 4 | BB |
MIDAZOLAM Children's Mercy Hospital Kansas City | Phase 4 | BB |
Purapo All Natural Medicine Clinic, LLC | Phase 1/2 | CC |
Smoliv All Natural Medicine Clinic, LLC | Phase 1/2 | CC |
View all 12 →
Same molecule, other indications
MANNITOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →